Scientific Sessions

Dr. Todd BullPH Around the World

At the Scientific Sessions at PHA's International PH Conference, researchers and healthcare professionals will have the opportunity to engage in educational sessions about PH practice and cutting-edge research. The theme of PHA's 2016 Scientific Sessions is PH Around the World, and presentations will discuss the differences in the diagnosis, epidemiology, pathophysiology, and medical management of PH and PAH between developed and developing regions in order to facilitate the development and dissemination of novel treatment strategies for these conditions.

Learning Objectives

After participating in this activity, participants will be able to:

  1. Describe individual characteristics of specific causes of PH worldwide.
  2. Discuss if and how interventions successfully used in the Western world can be applied in the developing world.
  3. Discuss how to leverage successes and failures in PH research over the past 25 years for the development of novel therapies and treatments.

Preliminary Scientific Sessions Schedule and Speakers

Thursday, June 16, 2016

16:30 ‐ 18:30 Scientific Sessions Poster Hall Reception

Friday, June 17, 2016

07:00 ‐ 08:00 Scientific Sessions Continental Breakfast
08:00 ‐ 08:15 Scientific Sessions Welcome and Introduction
Tim Lahm, MD, Indiana University, USA
08:15 ‐ 09:05 What has happened in the last 25 years: Global Perspectives/20 Years of Prostacyclins
Vallerie McLaughlin, MD, University of Michigan, USA
09:05 ‐ 09:20 Oral Abstract Presentation: 1002: PHD2 deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension recapitulating clinical PAH
Zhiyu Dai, PhD, University of Illinois College of Medicine, USA
09:20 ‐ 10:10 What Have We Learned from Modern Worldwide Registries?
David Badesch, MD, FACP, University of Colorado Denver, USA
10:10 ‐ 10:25 Oral Abstract Presentation: 1010: A selective TGFβ ligand trap attenuates pulmonary arterial hypertension
Dr. Lai-Ming Yung, Brigham and Women's Hospital, USA
10:25 ‐ 10:35 Coffee Break
10:35 ‐ 11:35 Etiologies of PH across the World
SchistosomiasisGhazwan Butrous, MD, PhD, University of Kent, UK
HIVChristopher Barnett, MD, MPH, Medstar Washington Hospital Center, USA
Drugs and ToxinsVinicio de Jesus Perez, MD, Stanford University, USA
High AltitudeErik Swenson, MD, University of Washington, USA
11:35 ‐ 11:50 Oral Abstract Presentation: 1051: Evidence of Fatty Acid Metabolic Defects and Right
Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension

Evan L. Brittain, MD, MSCI, Vanderbilt University, USA
11:50 ‐ 12:40 Panel Discussion: Enhancing Access to Drugs in Developing Countries, Challenges of Making
Generic Drugs Available in Developing Countries

Steven Kawut, MD, MS, University of Pennsylvania, USA
Mona Selej, MD, Actelion Pharmaceuticals, USA
Ghazwan Butrous, MD, PhD, University of Kent, UK
Professor Talant M. Sooronbaev, MD, Central Asia Pulmonary Hypertension (CAPH) PVRI Task
12:40 ‐ 12:55 Oral Abstract Presentation: 1042: A computer simulation model for atrial fenestration sizing
in pulmonary arterial hypertension with right ventricular failure

Joseph Kuruvilla, DO, Helen DeVos Children’s Hospital of Spectrum Health, USA
13:00 ‐ 14:30 PHA's International PH Conference General Opening Session
14:30 ‐ 15:20 Salvage Therapies in the U.S. and Europe versus Elsewhere
Tomas Pulido, MD, Instituto Nacional de Cardiologia, MX
Corey Ventetuolo, MD, MS, Brown University, USA
15:20 ‐ 16:10 Rethinking Pediatric PH ‐ International Aspects
Eric Austin, MD, MSCI, Vanderbilt University, USA
16:10 ‐ 16:25 Coffee Break
16:25 ‐ 17:15 From Bench to Bedside: Which Novel Pathways are Most Likely to be Harnessed
Therapeutically in the Next 25 Years?

Prof. Martin Wilkins, Imperial College London, UK
17:15‐17:30 Closing Remarks

PHA thanks the sponsors of the International PH Conference and Scientific Sessions:


Actelion Bayer Gilead






Accredo Specialty Pharmacy Reata Pharmaceuticals United Therapeutics logo


SteadyMed Therapeutics


Bellerophon Therapeutics Eiger BioPharmaceuticals

To support the International PH Conference and Scientific Sessions, please visit the sponsorship page.

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2016 Pulmonary Hypertension Association. All Rights Reserved.